World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
65
Citations
17045
World Ranking
2490
National Ranking
1010

Overview

Richard Haubrich is affiliated with the University of California, San Diego in the United States. Their research primarily focuses on medicine, with particular attention to infectious diseases, virology, neurology, emergency medicine, and epidemiology. The bulk of their scientific contributions are concentrated in infectious diseases, where they have published extensively.

The main topics covered in Richard Haubrich's research include:

  • HIV/AIDS drug development and treatment
  • COVID-19 clinical research studies
  • HIV research and treatment
  • HIV/AIDS research and interventions
  • Long-term effects of COVID-19
  • HIV-related health complications and treatments
  • SARS-CoV-2 and COVID-19 research

Their recent papers include the following:

  • "Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care" (2020), published in Clinical Infectious Diseases
  • "Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort" (2021), published in Clinical Infectious Diseases
  • "Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged ≥ 65 Years: Week 48 Results of a Phase 3b, Open-Label Trial" (2021), published in Infectious Diseases and Therapy
  • "Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality" (2021), published in Open Forum Infectious Diseases
  • "Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people ≥65 years of age" (2022), published in HIV Medicine

Among frequent co-authors collaborating with Richard Haubrich are:

  • Essy Mozaffari
  • Mark Thrun
  • Robert Gottlieb
  • Aastha Chandak
  • Paul Hodgkins

The researcher's work has appeared in a variety of publication venues, with multiple papers published in the following journals and repositories:

  • UNC Libraries
  • Open Forum Infectious Diseases
  • Clinical Infectious Diseases
  • Value in Health
  • HIV Medicine

Best Publications

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

    Scott M. Hammer;David A. Katzenstein;Michael D. Hughes;Holly Gundacker

  • Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

    Sharon A. Riddler;Richard Haubrich;A. Gregory DiRienzo;Lynne Peeples

  • The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group.

    Haubrich Rh;Little Sj;Currier Js;Forthal Dn

  • Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.

    Adriano Lazzarin;Thomas Campbell;Bonaventura Clotet;Margaret Johnson

  • Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

    Bonaventura Clotet;Nicholas Bellos;Jean Michel Molina;David Cooper

  • Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

    Antonella Castagna;Franco Maggiolo;Giovanni Penco;David Wright

  • Greater Tenofovir-Associated Renal Function Decline with Protease Inhibitor-Based versus Nonnucleoside Reverse-Transcriptase Inhibitor-Based Therapy

    Miguel Goicoechea;Shanshan Liu;Brookie Best;Shelly Sun

  • Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment.

    Richard H. Haubrich;Sharon A. Riddler;A. Gregory DiRienzo;Lauren Komarow

  • Comparison of Four-Drug Regimens and Pairs of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

    Robert W. Shafer;Laura M. Smeaton;Gregory K. Robbins;Victor De Gruttola

  • Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems

    Mari M Kitahata;Benigno Rodriguez;Richard Haubrich;Stephen Boswell

  • Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials.

    Christine Katlama;Richard Haubrich;Jacob Lalezari;Adriano Lazzarin

  • Therapeutic drug monitoring in HIV infection: current status and future directions.

    David J. Back;Giorgio Gatti;Courtney Fletcher;Rodolphe Garaffo

  • Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection

    Takuya Yamamoto;David A. Price;David A. Price;Joseph P. Casazza;Guido Ferrari

  • Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP.

    Jill Blumenthal;Sonia Jain;Douglas Krakower;Xiaoying Sun

  • Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection.

    Kristin L. Boswell;Robert Paris;Eli Boritz;David Ambrozak

  • HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins

    Zabrina L. Brumme;Zabrina L. Brumme;Mina John;Jonathan M. Carlson;Chanson J. Brumme

  • Effect of Influenza Vaccination on Viral Replication and Immune Response in Persons Infected with Human Immunodeficiency Virus Receiving Potent Antiretroviral Therapy

    Huldrych F. Günthard;Huldrych F. Günthard;Joseph K. Wong;Joseph K. Wong;Celsa A. Spina;Celsa A. Spina;Caroline Ignacio

  • Identification of Patients with Acute AIDS-Associated Cryptococcal Meningitis Who Can Be Effectively Treated with Fluconazole: The Role of Antifungal Susceptibility Testing

    Mallory D. Witt;Roger J. Lewis;Robert A. Larsen;Eric N. Milefchik

  • Dynamics of Total, Linear Nonintegrated, and Integrated HIV-1 DNA In Vivo and In Vitro

    Kersten K. Koelsch;Lin Liu;Richard Haubrich;Susanne May

Frequent Co-Authors

Douglas D. Richman
Douglas D. Richman University of California, San Diego
Eric S. Daar
Eric S. Daar Lundquist Institute
Davey M. Smith
Davey M. Smith University of California, San Diego
Roy M. Gulick
Roy M. Gulick Cornell University
Mina John
Mina John Royal Perth Hospital
Simon Mallal
Simon Mallal Vanderbilt University Medical Center
Joseph J. Eron
Joseph J. Eron University of North Carolina at Chapel Hill
David W. Haas
David W. Haas Vanderbilt University Medical Center
J. Allen McCutchan
J. Allen McCutchan University of California, San Diego
Susan J. Little
Susan J. Little University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various related fields, many of which can be pursued through flexible online programs. For instance, students interested in public health can explore online public health masters programs easy to get into, allowing a smooth transition into vital community health roles without overly competitive admission processes.

Beyond microbiology, healthcare careers such as becoming a child life specialist salary also attract graduates. This role involves supporting children and families in medical environments, making it a rewarding choice with competitive financial prospects.

Additionally, many online degrees cater to individuals with diverse backgrounds; what is the best degree for a convicted felon guides those seeking career opportunities despite past challenges, highlighting accessible programs that foster new beginnings.

For those inclined towards holistic healthcare, careers like a functional medicine nurse salary offer promising paths combining traditional nursing with alternative practices, often supported by targeted online education options.

Best Scientists Citing Richard Haubrich

Trending Scientists

Recently Published Articles